Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat

Journal of Physiology and Pharmacology

Volumn 58, Issue 2, 2007, Pages 349-360

  Bojanowska, Ewa ^a   Nowak, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Exendin 4; Food intake; Glucagon like peptide 1; Leptin; Water intake

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; LEPTIN;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FOOD INTAKE; MALE; NONHUMAN; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SINGLE DRUG DOSE;

ANIMALS; APPETITE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRUG SYNERGISM; EATING; GLUCAGON-LIKE PEPTIDE 1; LEPTIN; MALE; PEPTIDES; RATS; RATS, WISTAR; VENOMS;

EID: 34347406528     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Heymsfield SB, Greenberg AS, Fujioka K et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282: 1568-1575.
2. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94: 8878-8883.
3. Friedman JF. The functions of leptin in nutrition, weight, and physiology. Nutr Rev 2002; 60: S1-S14.
4. Fernandez-Galaz C, Fernandez-Agullo T, Perez C et al. Long-term food restriction prevents ageing-associated central leptin resistance in Wistar rats. Diabetologia 2002; 45: 997-1003.
5. Salvador J, Gomez-Ambrosi J, Fruhbeck G. Perspectives in the therapeutic use of leptin. EXPERT Opin Pharmacother 2001; 2: 1615-1622.
6. Konturek PC, Konturek JW, Cześnikiewicz-Guzik M, et al. Neuro-hormonal control of ford intake; basic mechanisms and clinical implications. J Physiol Pharmacol 2005; 56, Suppl. 6: 5-25.
7. Levin BE, Dunn-Meynell AA, Banks WA. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signalling before obesity onset. Am J Physiol 2004; 286: R143-R450.
8. Montez JM, Soukas A, Asilmas E, Fayzikhodjaeva G, Fantuzzi G, Friedman JM. Acute leptin deficiency, leptin resistance, and the physiologic response to leptin withdrawal. Proc Natl Acad Sci USA 2005; 102: 2537-2542.
9. Kosior-Korzecka U, Bobowiec R. Leptin effect on nitric oxide and GnRH-induced FSH secretion from ovine pituitary cells in vitro. J Physiol Pharmacol 2006; 57: 637-647.
10. Sahu A. Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004; 145: 2613-2620.
11. Goldstone AP, Morgan I, Mercer JG et al. Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem Biophys Res Commun 2000; 269: 331-335.
12. Sahu A. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J Neuroendocrinal 2002; 14: 796-804.
13. Ahren B. Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep 2003; 3: 365-3672.
14. Abbott CR, Small CJ, Sajedi A. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat. Int J Obes (Lond) 2006; 30: 288-292.
15. Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 1997; 94: 10455-10460.
16. Ladenheim EE, Emond M, Moran TH. Leptin enhances feeding suppression and neural activation produced by systemically administered bombesin. Am J Physiol 2005; 289: R473-R477.
17. Kastin AJ, Pan W, Akerstrom V, Hackler L, Wang C, Kotz CM. Novel peptide-peptide cooperation may transform feeding behavior. Peptides 2002; 23: 2189-2196.
18. Holz GG, Chepurny O. Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. Curr Med Chemistry 2003; 10: 2471-2483.
19. Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003; 52: 252-259.
20. Goldstone AP, Mercer JG, Gunn I et al. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 1997; 415: 134-138.
21. Kastin AJ, Akerstrom V, Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides 2001; 22: 2127-2136.
22. Kastin AJ, Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obesity 2003; 27: 313-318.
23. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 2004; 127: 546-58.
24. Tang-Christensen M, Vrang N, Larsen PJ. Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obesity 2001; Suppl 5: S42-S47.
25. Burdyga G, Spiller D, Morris R et al. Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience 2002; 109: 339-347.
26. Nakagawa A, Satake H, Nakabayashi H et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Autonomic Neurosci 2004; 110: 36-43.
27. 3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005; 146: 3748-3756.
28. Peters JH, Ritter RC, Simasko SM. Leptin and CCK modulate complementary background conductances to depolarize cultured nodose neurons. Am J Physiol 2006; 290: C427-C432.
29. Królczyk G, Laskiewicz J, Sobocki J, Matyja A, Kolasińska-Kloch W, Thor PJ. The effect of baclofen on the feeding behaviour and body weight of vagally stimulated rats. J Physiol Pharmacol 2005; 56: 121-131.
30. Ahima RS, Kelly J, Elmquist JK, Flier JS. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999; 140: 4923-4931.
31. Bray GM. Exenatide. Am J Health Syst Pharm 2006; 63: 411-418.
32. Baggio L, Adatia F, Bock T, Brubaker PL, Drucker DJ. Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice. J Biol Chem 2000; 275: 34471-34477.
33. Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 2001; 50: 2530-2539.
34. Bojanowska E, Stempniak B. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation. Physiol Behav 2003; 78: 73-79.
35. Göke R, Larsen PJ, Mikkelsen JD, Sheikh SP Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 1995; 7: 2294-2300.
36. Schulz C, Paulus K, Lehnert H. Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 2004; 145: 2696-2701.
37. Elmquist JK, Bjorbak C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395: 535-547.
38. Shioda S, Funahashi H, Nakajo S, Yada T, Maruta O, Nakai Y. Immunohistochemical localization of leptin receptor in the rat brain. Neurosci Lett 1998; 243: 41-44.
39. Rowland NE. The vagus nerve and thirst. Physiol Behav 2004; 82: 75-80.
40. Johnson RF, Johnson AK. The interaction of meal-related, rhythmic and homeostatic mechanisms and the generation of thirst and drinking. Braz J Med Biol Res 1997; 30: 487-491.